0000950170-24-085260.txt : 20240722 0000950170-24-085260.hdr.sgml : 20240722 20240722161653 ACCESSION NUMBER: 0000950170-24-085260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240721 FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erickson Anne CENTRAL INDEX KEY: 0002016865 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 241131710 MAIL ADDRESS: STREET 1: 1717 LANGHORNE NEWTOWN RD. SUITE 300 CITY: LANGHORNE STATE: PA ZIP: 19047 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 51285113796 MAIL ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 ownership.xml 4 X0508 4 2024-07-21 0001160308 Savara Inc SVRA 0002016865 Erickson Anne 1717 LANGHORNE NEWTOWN ROAD SUITE 300 LANGHORNE PA 19047 false true false false Chief Business Officer false Common Stock 2024-07-21 4 F false 381 4.47 D 353316 D Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. /s/ David Lowrance as attorney-in-fact for Anne Erickson 2024-07-22